Metric Finance
LearnFAQ
LearnFAQ

Learn / BNTX

NASDAQ: BNTX

BioNTech SE (BNTX) stock, explained like you're 5

BioNTech SE trades on the Nasdaq under the ticker BNTX. It is a large cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 24.4 billion dollars.

Ticker
BNTX
Exchange
Nasdaq
Sector
Healthcare
Industry
Biological Products (No Diagnostic Substances)
Size
Large cap, about 24.4 billion dollars

Is BioNTech SE a small, medium or large cap company?

Yes. BioNTech SE is a large cap stock. Its market cap, which is the total value of all its shares, is about 24.4 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How BioNTech SE makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves BNTX stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Another BioNTech Cancer Vaccine Just Hit a Major Setback. Is BNTX Stock Still a Buy? (The Motley Fool)
  • BioNTech SE (BNTX) stock price, news, quote and history (Yahoo Finance Australia)
  • BioNTech (BNTX) Stock Forecast and Price Target 2026 (MarketBeat)
  • BioNTech Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into BioNTech (BNTX) (Morningstar)
  • BioNTech Faces Setbacks in Clinical Trials Amid Pipeline Hopes (Intellectia AI)

Follow BNTX in your daily brief

Each trading day at 5 PM ET we post what happened to BioNTech SE and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow BNTX

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about BioNTech SE stock

What does BioNTech SE do?

BioNTech SE trades on the Nasdaq under the ticker BNTX. It is a large cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 24.4 billion dollars.

What is the ticker symbol for BioNTech SE?

BioNTech SE trades under the ticker BNTX on the Nasdaq.

What is BioNTech SE's market cap?

BioNTech SE is a large cap stock with a market cap of about 24.4 billion dollars.

How does BioNTech SE make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves BNTX stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow BNTX stock every day?

Add BNTX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow BNTX daily

A free brief on BioNTech SE and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • ARGX · Argenx SE
  • RVMD · Revolution Medicines
  • EXEL · Exelixis
  • NBIX · Neurocrine Biosciences

Similar stocks

  • ARGXArgenx SE
  • RVMDRevolution Medicines
  • EXELExelixis
  • NBIXNeurocrine Biosciences

Compare BNTX: BNTX vs ARGX, BNTX vs RVMD, BNTX vs EXEL

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed